This trial studies pleural tissue samples collected during biopsies to test a new method for determining the stage and prognosis of patients with malignant pleural mesothelioma. This new method may allow doctors to better classify cancer stage and give a better estimate for prognosis prior to surgery or another treatment.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03683680.
Locations matching your search criteria
United States
Massachusetts
Boston
Brigham and Women's HospitalStatus: Active
Contact: Raphael Bueno
PRIMARY OBJECTIVES:
I. To collect patients’ specimens in the course of routine biopsies to evaluate molecular tests mostly based on ribonucleic acid (RNA) expression.
OUTLINE:
Pleural tissue samples are collected from patients during diagnostic pleural biopsy, pleuroscopy, and/or video-assisted thoracoscopic surgery (VATS) resection and analyzed in the laboratory for biomarkers via reverse transcription polymerase chain reaction (RT-PCR) and RNA sequencing.
Trial PhaseNo phase specified
Trial Typediagnostic
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorRaphael Bueno
